Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

OptimizeRx (OPRX) Interest & Investment Income: 2011-2024

Historic Interest & Investment Income for OptimizeRx (OPRX) over the last 14 years, with FY2024 value amounting to $329000.0.

  • OptimizeRx's Interest & Investment Income fell 1495.33% to $91000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $359000.0, marking a year-over-year increase of 589.97%. This contributed to the annual value of $329000.0 for FY2024, which is 8499.09% down from last year.
  • OptimizeRx's Interest & Investment Income amounted to $329000.0 in FY2024, which was down 8499.09% from $2.2 million recorded in FY2023.
  • In the past 5 years, OptimizeRx's Interest & Investment Income ranged from a high of $2.2 million in FY2023 and a low of $16979.0 during FY2021
  • Over the past 5 years, OptimizeRx's median Interest & Investment Income value was $329000.0 (recorded in 2024), while the average stood at $691771.8.
  • In the last 5 years, OptimizeRx's Interest & Investment Income surged by 491971.85% in 2022 and then plummeted by 8499.09% in 2024.
  • Annual analysis of 5 years shows OptimizeRx's Interest & Investment Income stood at $68582.0 in 2020, then crashed by 75.24% to $16979.0 in 2021, then skyrocketed by 4919.72% to $852298.0 in 2022, then surged by 157.19% to $2.2 million in 2023, then crashed by 84.99% to $329000.0 in 2024.
  • Its Interest & Investment Income was $329000.0 in FY2024, compared to $2.2 million in FY2023 and $852298.0 in FY2022.